CSI Market
Sign In | Register

Xtant Medical Holdings Inc (XTNT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access XTNT quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Xtant Medical Holdings Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income4.97
Depreciation & amortization5.22
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase1.67
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.25
Share-based Compensation2.89
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Write Off Of Debt Discount-
Provision For Doubtful Accounts And Provision For Inventory Reserves-
Provision For Losses On Accounts Receivable And Inventory-
Gain Loss On Derivative Instruments Net Pretax-
Writeoffofdebtdiscount-
Noncashinterestexpense-
Purchase Accounting Valuation Allowance-
Provision For Excess And Obsolete Inventory-
Goodwill And Intangible Asset Impairment-
Noncash Interest0.54
Provision For Expected Credit Losses1.40
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities Other-0.08
Gain On Bargain Purchase-
Income taxes0.00
Gain (Loss) on Disposition of Stock in Subsidiary-3.28
Increase (Decrease) in Accounts Receivable-0.59
Increase (Decrease) in Accounts Payable-3.12
Increase (Decrease) in Accrued Liabilities4.20
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.54
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities12.55
Investing Activities
Capital Expenditures-2.38
Sale of Capital Items0.23
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Production Operations-
Proceed Advances From Pending Sales-
Proceeds From Divestiture10.05
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities7.90
Financing Activities
Short-term debt Net-1.26
Other borrowing transactions-0.05
Long-term debt - borrowings0.00
Long-term debt - repayments-8.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.07
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-6.22
Payment Of Royalties-
Payments Of Royalty Obligation-
Proceeds From Issuance Of Common Stock And Warrants-
Costs Associated With Exchange Of Debt For Common Shares-
Proceeds From Exercise Of Common Stock Warrants-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations6.22
Payment Of Taxes From Withholding Of Common Stock On Vesting Of Restricted Stock Units-0.13
Finance Lease Principal Payments-0.07
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-9.57
Effect of exchange rate on cash flow0.23
Discontinued operations0.00
Free Cash Flow10.40
Total Cash Flow11.11
4 historic quarters locked

Sign in to unlock the full Xtant Medical Holdings Inc cash flow history.

Sign In Create Free Account

About Xtant Medical Holdings Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-013792

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License